The goal is to investigate the effects of opioids on neuroendocrine function in developing rats. The rationale is based on clinical finding of disrupted growth and CNS development following perinatal opiate addiction, and the growing evidence that endogenous opioids are important regulators of normal neuroendocrine ontogeny. Opioid effects on reproductive development will be studied. Endogenous opioids are thought to contribute to pubertal development, and so this system is a primary target, and a good model for studying perinatal opioid effects. Opioid agonist treatments should retard, and antagonists accelerate puberty. Vaginal opening, the establishment of normal estrus cycles and preputial separation will be followed after treatment with the opioid agonist methadone or the antagonist naltrexone. Serum levels of LH, estradiol, testosterone, hypothalomoc LHRH, pituitary LH and hypothalamic norepinephrne turnover will be measured to investigate specific mechanisms. The second major goal is to characterize further the dual neural control of opioid-induced prolactin (PRL) secretion. We have shown that opioid-induce induced PRL secretion changes from a serotonin (5HT)-independent to a 5HT-dependent process during ontogeny. Effects of dopamine (DA) and opioid drugs on hormone secretion and studies of 5HT and DA turnover will be used to identify specific mechanisms mediating these two responses. Finally, the role of different opioid receptor subtypes in neuroendocrine regulation will be defined further, with an emphasis on delineating the ontogeny of receptor subtype-specific GH, PRL, LH, ACTH, and TSH responses, and the differential development of tolerance at these receptors. These studies should provide insight into normal and disrupted function of endogenous opioid systems, which appear to supply a """"""""primitive"""""""" control of hormone secretion before other neural controls mature. These studies have clinical relevance for the considerable population of women who are exposed to opiates through drug abuse or through physiologically-induced secretion association with activities like excessive exercise.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
2R01DA002739-07
Application #
3207545
Study Section
(DABA)
Project Start
1980-07-01
Project End
1988-07-31
Budget Start
1986-09-01
Budget End
1987-07-31
Support Year
7
Fiscal Year
1986
Total Cost
Indirect Cost
Name
Duke University
Department
Type
Schools of Medicine
DUNS #
071723621
City
Durham
State
NC
Country
United States
Zip Code
27705
Rincavage, Heather L; McDonnell, Donald P; Kuhn, Cynthia M (2003) Expression of functional estrogen receptor beta in locus coeruleus-derived Cath.a cells. Endocrinology 144:2829-35
Ceger, P; Kuhn, C M (2000) Opiate withdrawal in the neonatal rat: relationship to duration of treatment and naloxone dose. Psychopharmacology (Berl) 150:253-9
Hepburn, M J; Little, P J; Gingras, J et al. (1997) Differential effects of naltrindole on morphine-induced tolerance and physical dependence in rats. J Pharmacol Exp Ther 281:1350-6
Little, P J; Price, R R; Hinton, R K et al. (1996) Role of noradrenergic hyperactivity in neonatal opiate abstinence. Drug Alcohol Depend 41:47-54
Little, P J; Kuhn, C M; Wilson, W A et al. (1996) Differential effects of ethanol in adolescent and adult rats. Alcohol Clin Exp Res 20:1346-51
Windh, R T; Little, P J; Kuhn, C M (1995) The ontogeny of mu opiate tolerance and dependence in the rat: antinociceptive and biochemical studies. J Pharmacol Exp Ther 273:1361-74
Little, P J; Kuhn, C M (1995) Ontogenetic studies of tolerance development: effects of chronic morphine on the hypothalamic-pituitary-adrenal axis. Psychopharmacology (Berl) 122:78-84
Windh, R T; Kuhn, C M (1995) Increased sensitivity to mu opiate antinociception in the neonatal rat despite weaker receptor-guanyl nucleotide binding protein coupling. J Pharmacol Exp Ther 273:1353-60
Blackford, S P; Little, P J; Kuhn, C M (1992) Mu- and kappa-opiate receptor control of prolactin secretion in rats: ontogeny and interaction with serotonin. Endocrinology 131:2891-7
Ignar, D M; Windh, R T; Kuhn, C M (1992) Chronic administration of U50,488H fails to produce hypothalamo-pituitary-adrenal axis tolerance in neonatal rats. Neuropharmacology 31:143-8

Showing the most recent 10 out of 24 publications